Short-term vs. overnight insemination: which one is better for patients with only one or two oocytes retrieved in IVF cycles?

Read full text
Authors: Jinghua Chen, Zhenfang Liu, Jiajun Cai, Xiaoming Jiang, Luxiang Pan, Liying Zhou, Kaijie Chen, Xiaolian Yang, Yurong Chen, Lanlan Liu, Jianzhi Ren
Cited by: 0
References: 42

Abstract

Background: Compared with overnight insemination, it remains uncertain whether short-term insemination can improve outcomes in poor responders, and few studies have used cumulative live birth rate as the primary endpoint. The study aims to compare the effects of short-term insemination and overnight insemination on poor responders with one or two oocytes by evaluating cumulative live births. Methods: A retrospective study was conducted on 2,392 cycles, which were divided into the short-term insemination group (5 h) and the overnight insemination group (17 h) based on gametes' incubation time. Basic characteristics and clinical outcomes were compared and analyzed using propensity score matching. Results: > 0.05). Multivariate logistic regression analysis confirmed that short-term insemination had no adverse effect on the cumulative live birth rate (CLBR). However, in the subgroup of patients who underwent extended culture of all embryos, comparing overnight to short-term insemination, the odds ratios (ORs) for CLBR were 0.40 (95% CI: 0.18-0.88) in the unmatched cohort and 0.39 (95% CI: 0.18-0.84) in the matched cohort. Conclusions: Our analysis suggests that for IVF cycles with a limited oocyte yield (1-2), short-term insemination does not adversely affect the CLBR. Furthermore, it may demonstrate a potential benefit for the subset of patients whose clinical pathway involves the extended culture of all embryos to the blastocyst stage.

Fields of Study & Subjects

Reproductive Biology and Fertility Reproductive Health and Technologies Assisted Reproductive Technology and Twin Pregnancy

Publication details

Journal / source
Frontiers in Endocrinology
Volume
17
Pages
1647862–1647862
Publication date
3 February 2026
Language
EN